Nuvation Bio
NUVB • NYSE
Nuvation Bio is a biotechnology company in the healthcare sector trading on NYSE, led by CEO David T. Hung, with a market cap of $1.6B.
Market Cap$1.6B
Employees159.0
CEODavid T. Hung
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
Nuvation Bio FAQ
Common questions about Nuvation Bio
Nuvation Bio is scheduled to report earnings for Q1 2026 on May 6, 2026. Analysts estimate revenue of $72.2M.
Nuvation Bio has approximately 159 employees.